Transportan 10 can either slip through cancer cell membranes at low concentrations or destroy them by forming pores at high concentrations, with the behavior captured in real time using advanced fluorescence microscopy.
Concentration-dependent dual mechanismTP10 translocates across cancer cell membranes at low concentrations but forms pores and collapses membranes at high concentrations — a critical finding for therapeutic design
What the researchers found
Using fluorescence lifetime imaging microscopy (FLIM) with phasor analysis, researchers visualized TP10's behavior on cancer cell-derived membrane vesicles in real time. They identified concentration-dependent mechanisms: at lower concentrations, TP10 translocated across membranes and accumulated in the vesicle lumen (internalization). At higher concentrations, it induced membrane perturbation, pore formation, and ultimately membrane collapse and disruption. The FLIM-phasor approach enabled monitoring of these spatially heterogeneous, highly dynamic events as they occurred.
Why it matters
Cell-penetrating peptides are being developed for both drug delivery and direct anticancer activity, but the mechanisms by which they interact with cell membranes are poorly understood. This study provides the first real-time visualization of how concentration determines whether a CPP acts as a quiet delivery vehicle or a membrane-destroying weapon. This knowledge is essential for safely designing peptide-based therapeutics — using the right concentration for delivery without causing unwanted cell death, or deliberately using higher concentrations for anticancer effects.
How the study worked
Researchers generated giant plasma membrane vesicles (GPMVs) from cancer liver cells to study membrane interactions in a controlled system. They used fluorescence lifetime imaging microscopy (FLIM) coupled with phasor approach analysis to track TP10's behavior at the membrane in real time. Different peptide concentrations were tested to map the transition from translocation to membrane disruption.
What this study cannot tell us
The study used giant plasma membrane vesicles (GPMVs) derived from cancer cells, which are simplified models lacking the full complexity of living cells (no cytoskeleton, intracellular organelles, or active repair mechanisms). Results may not translate directly to intact cells or in vivo conditions. Only cancer liver cells were used as the membrane source, so the findings may not apply to all cell types. No drug cargo delivery was tested.
How to read the evidence
This is a basic biophysics study using simplified membrane vesicle models and advanced imaging. The real-time mechanistic observations are technically impressive, but the system is far from clinical relevance — no living cells, no in vivo data, no therapeutic application tested.
When this study was published
Published in 2023 in Biomolecules, this is recent work that advances the mechanistic understanding of cell-penetrating peptides using state-of-the-art fluorescence imaging techniques.
The bigger picture
The field of peptide-based drug delivery needs to understand exactly how peptides cross cell membranes to deliver cargo safely. TP10 is one of the most studied cell-penetrating peptides, and this work reveals that the boundary between safe delivery and membrane destruction is concentration-dependent. As CPPs advance toward clinical applications in cancer therapy and drug delivery, studies like this help define the therapeutic window where peptides can deliver drugs without killing the target cells — or where killing cells is exactly the goal.
Questions still open
- At what precise concentration does TP10 transition from safe membrane translocation to destructive pore formation in living cancer cells?
- Could the membrane-disrupting activity of TP10 at high concentrations be harnessed as a targeted anticancer therapy?
- Do different cancer cell types show different sensitivity thresholds for TP10-induced membrane disruption?
Common questions
What is Transportan 10 and where does it come from?
Why does the same peptide sometimes enter cells gently and sometimes destroy them?
Read the original research
Transportan 10 Induces Perturbation and Pores Formation in Giant Plasma Membrane Vesicles Derived from Cancer Liver Cells.
Biomolecules, 13(3)
Citation
Anselmo, Sara; Sancataldo, Giuseppe; Baiamonte, Concetta; Pizzolanti, Giuseppe; Vetri, Valeria. (2023). Transportan 10 Induces Perturbation and Pores Formation in Giant Plasma Membrane Vesicles Derived from Cancer Liver Cells.. Biomolecules, 13(3). https://doi.org/10.3390/biom13030492